Trademarkia Logo

Canada

C$
ALAUNOS THERAPEUTICS
SEARCHED

on 19 Sept 2023

Last Applicant/ Owned by

ALAUNOS THERAPEUTICS INC.

2617 Bissonnet, Suite 225Houston TX 77005

US

Serial Number

2189458 filed on 28th Apr 2022

Correspondent Address

CATHERINE M. DENNIS BROOKS

(MILLER THOMSON LLP)SCOTIA PLAZA40 KING STREET WEST, SUITE 5800, P.O. BOX 1011TORONTO

ONTARIO

CA

M5H3S1

ALAUNOS THERAPEUTICS

Trademark usage description

pharmaceuticals for the treatment of cancer; biochemical and biopharmaceutical preparations for the treatment of cancer; gene therapy products, namely Read More

Classification Information


Class [005]
Pharmaceuticals for the treatment of cancer; biochemical and biopharmaceutical preparations for the treatment of cancer; gene therapy products, namely, genetically engineered materials in the nature of immune cells for the treatment of cancer; cells for medical or clinical use; preparations for genetically modifying human and animal cells for diagnostic and medical purposes; preparations of blood or cells extracted from humans or animals which have been adapted for therapeutic purposes.


Classification kind code

11

Class [042]
Medical research.


Classification kind code

11

Class [044]
Cell therapy services; gene therapy services.


Classification kind code

11

Mark Details


Serial Number

2189458

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 22
on 19th Sept 2023
Search Recorded
Submitted for opposition 20
on 19th Sept 2023
Examiner's First Report
Submitted for opposition 223
on 19th Sept 2023
Total Provisional Refusal
Submitted for opposition 256
on 3rd Apr 2023
Notification of Possible Opposition Sent
Submitted for opposition 48
on 13th Jul 2022
Agent Changed
Submitted for opposition 257
on 2th Jun 2022
Designation Notification - Madrid Protocol
Submitted for opposition 31
on 1st Jun 2022
Formalized
Submitted for opposition 1
on 1st Jun 2022
Created
Submitted for opposition 228
on 28th Apr 2022
International Registration
Submitted for opposition 30
on 28th Apr 2022
Filed